Medicinova (MNOV) Enterprise Value (2010 - 2025)
Medicinova's (MNOV) quarterly Enterprise Value came in at -$30.8 million in Q4 2025, up 23.67% year-on-year from -$24.9 million in Q4 2024, and up 5.39% on a QoQ basis from -$32.6 million in Q3 2025.
Medicinova (MNOV) Enterprise Value (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Enterprise Value data on file, last reported at -$30.8 million in Q4 2025.
- On a quarterly basis, Enterprise Value rose 23.67% year-over-year to -$30.8 million in Q4 2025; TTM through Dec 2025 was -$30.8 million, a 23.67% increase from a year earlier, with the FY2025 full-year figure at -$30.8 million, up 23.67% from the prior year.
- Enterprise Value for Q4 2025 stood at -$30.8 million, up from -$32.6 million in the prior quarter.
- Over the last five years, Enterprise Value for MNOV reached as high as -$30.8 million in Q4 2025 and fell as low as -$77.8 million in Q2 2021.
- Historically, Enterprise Value has averaged -$53.2 million across 5 years, with a median of -$52.0 million in 2022.
- Across the five-year window, Enterprise Value slipped 28.71% in 2021 and soared 30.01% in 2022, its largest moves.
- Year by year, Enterprise Value stood at -$71.4 million in 2021, then grew by 18.12% to -$58.5 million in 2022, then climbed by 12.8% to -$51.0 million in 2023, then climbed by 20.86% to -$40.4 million in 2024, then gained by 23.67% to -$30.8 million in 2025.
- Per Business Quant data, the three most recent Enterprise Value figures were -$30.8 million in Q4 2025, -$32.6 million in Q3 2025, and -$34.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | -30.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.81 Mn |
| Sep 30, 2025 | -32.56 Mn |
| Jun 30, 2025 | -34.26 Mn |
| Mar 31, 2025 | -36.57 Mn |
| Dec 31, 2024 | -40.36 Mn |
| Sep 30, 2024 | -42.28 Mn |
| Jun 30, 2024 | -44.34 Mn |
| Mar 31, 2024 | -47.14 Mn |
| Dec 31, 2023 | -51.00 Mn |
| Sep 30, 2023 | -51.51 Mn |
| Jun 30, 2023 | -52.88 Mn |
| Mar 31, 2023 | -55.26 Mn |
| Dec 31, 2022 | -58.49 Mn |
| Sep 30, 2022 | -52.51 Mn |
| Jun 30, 2022 | -65.23 Mn |
| Mar 31, 2022 | -67.70 Mn |
| Dec 31, 2021 | -71.43 Mn |
| Sep 30, 2021 | -75.03 Mn |
| Jun 30, 2021 | -77.79 Mn |
| Mar 31, 2021 | -76.30 Mn |